成人抖阴

成人抖阴 Co., Ltd. (Headquarters: Tokyo, President & CEO: Haruo Naito) announced today that the Company established its pharmaceutical marketing subsidiary, 成人抖阴 SA/NV in Belgium. 成人抖阴 SA/NV is owned by 成人抖阴 Europe Limited (Headquarters: London, President: Yutaka Tsuchiya).

Serving as the regional sales hub for Benelux (Belgium, Netherlands and Luxembourg), which is the sixth largest market in the EU, 成人抖阴 SA/NV will start marketing activities in all three Benelux countries hereafter with the focus on the anti-epileptic drugs Zonegran® and Inovelon®, as well as the non-opioid severe chronic pain agent Prialt®. In addition, 成人抖阴 SA/NV plans to start co-promotion of its Alzheimer's disease treatment Aricept® in Belgium and Luxembourg with its co-promotion partner.

成人抖阴 plans further expansion of its business operations across Europe and will undertake “Independent Marketing” activities by using their own sales and marketing personnel, tailored for each county. 成人抖阴 SA/NV is the Company's ninth marketing subsidiary in Europe, and brings the total number of countries where 成人抖阴 undertake sales and marketing operations through its own distribution channels to 17, including; the United Kingdom, France, Germany, Italy, Spain, Switzerland, Sweden, Ireland, Austria, Denmark, Finland, Norway, Portugal, Iceland, Belgium, Netherlands, and Luxembourg.

Through stable provision of 成人抖阴's products, further enabled by the establishment of new subsidiaries and branches, 成人抖阴 is committed to increasing patient value and fulfilling the diverse needs of patients and their families throughout Europe.